Charles M Blazey
Inventor
Stats
- 14 US patents issued
- 21 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 14 US Patents Issued
- 21 US Applications Filed
- 266 Total Citation Count
- May 23, 2024 Most Recent Filing
- Jul 23, 2004 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| EXELIXIS, INC. | 2
2 4 2 5 2 1 1 | 2004
2005 2006 2008 2010 2011 2013 2015 |
| EXELIXIS PATENT COMPANY LLC | 2
2 | 2005
2010 |
| SYMPHONY EVOLUTION, INC. | 2
3 2 | 2009
2013 2015 |
Inventor Addresses
| Address | Duration |
|---|---|
| San Francisco, CA | Feb 08, 07 - Jan 10, 08 |
| San Francisco, CA, US | Jun 18, 09 - Mar 27, 25 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 2 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 14 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 8 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2025/0100,966 | 2025 | MEK INHIBITORS AND METHODS OF THEIR USE | 0 |
| 2020/0283,383 | 2020 | MEK Inhibitors and Methods of Their Use | 0 |
| 2020/0031,770 | 2020 | MEK INHIBITORS AND METHODS OF THEIR USE | 0 |
| 2019/0144,382 | 2019 | MEK Inhibitors and Methods of Their Use | 0 |
| 10266518 | 2019 | Solid dosage formulations of substituted quinazoline receptor-type kinase modulators and methods of use thereof | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.